Francois J. Lebel
2020
In 2020, Francois J. Lebel earned a total compensation of $2.2M as Executive Vice President and Chief Medical Officer at Spectrum Pharmaceuticals, a 17% decrease compared to previous year.
Compensation breakdown
| Bonus | $270,000 |
|---|---|
| Option Awards | $847,754 |
| Salary | $540,000 |
| Stock Awards | $450,001 |
| Other | $116,763 |
| Total | $2,224,518 |
Lebel received $847.8K in option awards, accounting for 38% of the total pay in 2020.
Lebel also received $270K in bonus, $540K in salary, $450K in stock awards and $116.8K in other compensation.
Rankings
In 2020, Francois J. Lebel's compensation ranked 5,045th out of 13,090 executives tracked by ExecPay. In other words, Lebel earned more than 61.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,045 out of 13,090 | 62nd |
Division Manufacturing | 2,063 out of 5,624 | 63rd |
Major group Chemicals And Allied Products | 823 out of 2,257 | 64th |
Industry group Drugs | 712 out of 1,957 | 64th |
Industry Pharmaceutical Preparations | 537 out of 1,462 | 63rd |
Source: SEC filing on April 27, 2022.
Lebel's colleagues
We found four more compensation records of executives who worked with Francois J. Lebel at Spectrum Pharmaceuticals in 2020.